KAYLI SCHOU: Open Payments
NPI 1649835455 · LAKE SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 43 payments from 16 companies in 2025. Trend: 2023 $1,918 · 2024 $1,372 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $154 |
| Lilly USA, LLC | 6 | $112 |
| Novo Nordisk Inc | 4 | $74 |
| Corcept Therapeutics | 2 | $59 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Globus Medical, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
Products named: VRAYLAR, JARDIANCE, Korlym, TRELEGY ELLIPTA, REXULTI, Kerendia, Senza, Ozempic.
Industry payments across MO — which companies pay providers there.
